<http://schema.org/description>
" Swiss pharmaceutical giant Novartis said Sunday the expiry of a US patent for its leading hypertension drug Diovan caused a drop in turnover that could last into the first half of 2013."^^<http://www.w3.org/2001/XMLSchema#string>
<http://medicalxpress.com/news/2012-10-novartis-chief-sales-dip-mid-.html>